Editor’s note: Arcturus CEO Joe Payne is set to give a company presentation Wednesday at the BIO 2014 convention in San Diego. —BVB Medicinal chemistry has come a long way since the first opiates were “prescribed” in 3500 B.C. Since then, we have seen advancements of science usher in over 1,100 FDA-approved drugs—with a substantial … Continue reading “BIO 2014: Why San Diego is a Hub for RNA R&D and Drug Development”
Author: Joseph Payne
Joseph Payne, is co-founder, CEO, and chairman of San Diego-based Arcturus Therapeutics, which is advancing proprietary technology for developing RNAi-based drugs targeting orphan diseases. He has over 20 years of successfully drug discovery experience at Merck Research Labs, DuPont Pharmaceuticals, Bristol-Myers Squibb, Kalypsys, and Nitto Denko. He has over 40 publications and patents and seven investigational new drug candidates.
His academic training includes Brigham Young University (magna cum laude, Chemistry and Physics), University of Calgary (Synthetic Organic Chemistry), and MIT Sloan School of Management (Executive Training, Supply Chain and Logistics Strategy).